vimarsana.com

Page 4 - Williamf Feehery News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Certara Announces the Completion of Arsenal Capital Partners Investment and the Appointment of David Spaight to the Board of Directors

Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private EquityPRINCETON, N.J., Dec. 08, 2022 (GLOBE NEWSWIRE) Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”).

Ethan waxmanJackie schofieldDavid deuchlerWilliamf feeheryDavid spaightEric liuStephen mcleanResearch laboratoriesGilmartin groupFisher scientificPharma servicesCertara incArsenal capital partnersOperating partnerSenior partnerChief executive officer

Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module

BioPharma

Williamf feeheryMax kanevskyCertara softwareData exchangeCertara incRejection criteria

Certara Appoints Rosemary Crane as New Independent Board Member

Certara Appoints Rosemary Crane as New Independent Board Member - read this article along with other careers information, tips and advice on BioSpace

David deuchlerAriane lovellWilliamf feeheryJieunw choeBristol myers squibbTarsus pharmaceuticals nasdaqCertara incTeva pharmaceuticalsSpecialty pharmaceuticalsCatalent pharma solutionsNutritional groupRosemary craneChief executive officerGroup chairmanTarsus pharmaceuticalsVice chairman

vimarsana © 2020. All Rights Reserved.